Spatial analysis of tumor tissue that maps the tumor microenvironment, cell by cell.
Consented intake · your records travel with you · nothing moves without your sign-off
These CLIA labs use Ultivue, Akoya, and NanoString technologies for spatial analysis, including single cell analysis, flow cytometry, CODEX multiplex imaging, and immunohistochemistry staining. The work maps the tumor microenvironment, especially cancer heterogeneity and immune cell proliferation, giving patients a detailed view of the tumor's makeup.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how CLIA labs using Ultivue, Akoya, and NanoString technologies (TBD) handles billing.
We don't have confirmed insurance details for CLIA labs using Ultivue, Akoya, and NanoString technologies (TBD) yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in CLIA's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Matches your tumor's biomarkers to the therapies most likely to work for you — mapping your molecular profile to targeted and approved options.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.